Culture

Charge radii of exotic potassium isotopes challenge nuclear structure theory

image: The measuremenst were made using the Collinear Resonance Ionization Spectroscopy technique at CERN, ISOLDE.

Image: 
CERN

In nuclear physics so-called magic number are such nuclear proton and/or neutron numbers, for which the nucleus is more stable compared to neighboring isotopes on the nuclear chart. Researchers in both experimental and theoretical nuclear physics from University of Jyväskylä, Finland, took part of international research team, which studied the nuclear charge radii of potassium isotopes. Isotopes were studied by using the collinear resonance ionization spectroscopy technique. The results indicated that the potassium isotope with a neutron number of 32 does not conform with criteria of magic neutron number. The results were published in Nature Physics journal on January 2021.

Far from the stable isotopes which we know well from the periodic table, in region of the so-called exotic nuclei, an extreme ratio of protons and neutrons lead to the emergence of new phenomena which test our understanding of the nuclear forces.

One well known feature of these forces is that some nuclei with certain number of protons and/or neutrons are more stable than their neighboring isotopes. We refer to these numbers as magic numbers. They lead to longer half-lives and among others, a smaller size than would be expected for a non-magic nucleus.

In the mass region of the potassium isotopes, 32 was proposed as a new magic number for neutrons. The experimental study of these special regions of the nuclear chart is crucial to unveil new phenomena, and through comparison with state-of-the-art nuclear theory, test how well we understand them.

However, in practice, these isotopes can only be produced at accelerator facilitates, and there only in minute samples. This drives continuous developments in experimental techniques, for increased efficiency and sensitivity to the nuclear properties we wish to measure.

Modification to setup to measure nuclear charge radius of 52K

In this research researchers performed laser spectroscopy studies on the exotic potassium isotopes using the Collinear Resonance Ionization Spectroscopy (CRIS) technique at CERN, ISOLDE.

"For the measurement of the potassium isotope with 33 neutrons (52K), we modified our setup to increase the selectivity of the method, by detecting the decay of this isotope, thus reducing the background noise introduced by stable species. This allowed for the measurement of nuclear charge radius of 52K", says post doctoral researcher Agota Koszorus from the University of Liverpool, who is now based at the University of Jyväskylä.

"If the size of this isotope was significantly larger than its proposed magic neighbor, 51K, we would have confirmed the magic nature of the neutron number 32. However, our results show a continuously increasing trend, implying that 32 neutrons don't have a special stabilizing affecting on the nuclear size", she concludes.

On theory side, the nuclear structure of potassium isotopes were modeled with two different theoretical approaches, namely with the nuclear density functional theory (DFT) and the coupled cluster (CC) theory.

"The DFT is an ideal method for heavier nuclei, whereas CC is more suitable for light and medium mass nuclei. The potassium region offers an ideal meeting ground to test these approaches simultaneously. Both theoretical methods need information about the nuclear interactions. For this purpose, state-of-the art nuclear structure models were applied: The DFT calculations employed highly successful Fayans energy density functional and CC calculations used the latest ab-initio chiral potential", says Associate Professor Markus Kortelainen from the Department of Physics at the University of Jyväskylä.

While both theoretical approaches reproduced the general experimental trend of charge radius isotopic shifts, some shortcomings were noted. The DFT results showed a notable overestimation of charge radius staggering between neighboring odd and even neutron number isotopes, whereas the CC calculations had difficulties to reproduce experimental trend in heavier isotopes. These observations urge to further improve present nuclear structure models.

Credit: 
University of Jyväskylä - Jyväskylän yliopisto

Large-area periodic perovskite nanostructures for lenticular printing laser displays

image: Green- and red-light emission observed at high and low view angles from the periodic nanostructures of mixed-halide perovskite CH3NH3PbBrxI3-x.

Image: 
@Science China Press

Lead halide perovskites, with high refractive index and excellent optoelectronic property, have been used in both constructing high-quality optical resonators/lasers and fabricating high-efficiency light-emitting devices for advanced displays. Lenticular printing provides an illusion of depth and shows varying images upon view angles, which is considered as a promising approach towards future stereoscopic displays. To realize lenticular-printing-based display, it is required to modulate the outcoupling direction of emission light rather than that of incident light. Ideally, the lenticular-lens-like structures would be integrated into the active layer of light-emitting devices. Therefore, the hybrid perovskite becomes a promising candidate for the investigation of lenticular printing display; however, it remains a challenge to realize large-area periodic structures of perovskite materials especially with a feature size of wavelength scale.

Very recently, Dr. Chuang Zhang, Dr. Yong Sheng Zhao from Institute of Chemistry, Chinese Academy of Sciences, Dr. Yuchen Wu from Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, and their colleagues fabricated lead halide perovskite periodic structures via a space-confined solution growth method. The spatial resolution could be down to hundreds of nanometers while the substrate size up to several centimeters. These structures were able to not only modulate the reflection of visible light, but also control the angle of light emission from hybrid perovskites. More importantly, the low-threshold lasing based on distributed feedback was observed from the periodic structures, and its narrow line-width offered possibility to realize the lenticular printing laser display, according to the wavelength-dependent outcoupling of emission colors. A prototype of laser display panels was then realized based on the mixed halide perovskites, in which the green and red colored images were obtained at high and low angles respectively. This work would shed light on the design and fabrication of perovskites materials for new types of display techniques.

Credit: 
Science China Press

In symbiosis: Plants control the genetics of microbes

image: Each spore contains hundreds of nuclei. The image was generated using confocal microscopy. The bright spots within the spores represent nuclei labelled with fluorescent dye. Images are colour coded along z-axis for depth recognition, with white and red colours being closer to the observer while blue colours being the furthest. Each image is the result of approximately 300 z-stacks (0.35um intervals).

Image: 
University of Ottawa/ Microscope Laboratory (Ottawa-RDC, Agriculture and Agri-Food Canada)

Researchers from the University of Ottawa have discovered that plants may be able to control the genetics of their intimate root symbionts - the organism with which they live in symbiosis - thereby providing a better understanding of their growth.

In addition to having a significant impact on all terrestrial ecosystems, their discovery may lead to improved eco-friendly agricultural applications.

We talked to research lead Nicolas Corradi, Associate Professor in the Department of Biology and Research Chair in Microbial Genomics at the University of Ottawa, and lead author Vasilis Kokkoris, Postdoctoral Fellow in the Corradi Lab, in partnership with Agriculture and AgriFood Canada (Stefani Lab and Dettman Lab), to learn more about their recent study published in the journal Current Biology.

Can you tell us more about your findings?

Nicolas Corradi: "We have uncovered a fascinating genetic regulation between plants and their microbial symbionts, known as Arbuscular Mycorrhizal Fungi (AMF).

AMF are plant obligate symbionts that grow within the plant roots and help their hosts to grow better and be more resistant to environmental stressors.

AMF genetics have long been mysterious; while typical cells carry one nucleus, the cells of AMF carry thousands of nuclei that can be genetically diverse. How these nuclei communicate with each other and whether the plants can control their relative abundance, has been a total mystery.

Our work provides insights into this unique genetic condition:

1- We demonstrate that the host plant symbiont influences the relative abundance of thousands of co-existing nuclei carried by their fungal symbionts.

2- We find evidence that co-existing nuclei of different genetic backgrounds cooperate, rather than compete with one another thus potentially maximizing growth benefits for both the fungi and their plant partners."

How did you come to these conclusions?

Vasilis Kokkoris: "We implemented a novel molecular approach accompanied by advanced microscopy and mathematical modelling. Every single AMF spore carries hundreds of nuclei (see image).

By analyzing single spores, we were able to quantify the genetics of thousands of nuclei and define their relative abundance in different fungal strains and across plant species.

To ensure that we accurately analyze single nuclei, we used advanced microscopy to visualize and count the nuclei in the spores.

Lastly, we used mathematical modelling to prove that the observed abundance of nuclear genotypes we identified cannot be a product of luck but instead is the result of a driven cooperation between them.

To better understand what is regulating the AMF nuclei we grew different AMF strains with different hosts and found that plants have control of the relative abundance of the fungal nuclei."

What are the impacts of your discovery?

Nicolas Corradi: "For many years, AMF have been considered to be genetic peculiarities and far away from model organisms. Inconsistencies are commonly observed in plant-AMF experiments. For example, growing the same fungal strain with different plants can lead to drastically different plant yields. For a long time, this variance in plant growth was blamed on the AMF mysterious genetics.

Our research provides an answer as we demonstrate that the genetics of these fungi, and their effect on plant growth, can be manipulated by plants thus explaining the reason for the observed variability on plant growth.

From an environmental standpoint, this new knowledge allows for better understanding how plants can influence the genetics of their symbiotic partners, thus influencing entire terrestrial ecosystems.

From an economic standpoint, it opens doors to improved sustainable agricultural applications."

Credit: 
University of Ottawa

Experimental vaccine blunts the deadliest of synthetic opioids

LA JOLLA, CA--As the opioid epidemic raged on with an even greater force during COVID-19, the Scripps Research laboratory of chemist Kim Janda, PhD, has been working on new therapeutic interventions that may be able to prevent the bulk of deaths from opioid overdose.

Janda and his team have developed experimental vaccines that have shown in rodents to blunt the deadly effects of fentanyl--which has been driving the boom in opioid deaths--as well as its even more fatal cousin, carfentanil, a growing source of overdoses and a chemical terrorist threat.

"Synthetic opioids are not only extremely deadly, but also addictive and easy to manufacture, making them a formidable public health threat, especially when the coronavirus crisis is negatively impacting mental health," says Janda, the Ely R. Callaway, Jr. Professor of Chemistry at Scripps Research. "We've shown it is possible to prevent these unnecessary deaths by eliciting antibodies that stop the drug from reaching the brain."

Once in the brain, synthetic opioids trigger the body to slow down breathing. When too much of the drugs are consumed, which is easy to do, breathing can stop altogether. In a series of experiments involving mice, Janda's vaccines "sequestered" the potent drug molecules to keep them from interacting with the brain and body, thus thwarting dangerous respiratory symptoms.

Findings appear today in ACS Chemical Biology, published by the American Chemical Society.

Janda envisions the vaccine being used in a number of scenarios, including emergency situations to treat overdoses, as a therapy for those with substance abuse disorder, and as a means to protect military personnel who may be exposed to opioids as chemical weapons. They may even be helpful for police dogs that are trained seek out these deadly drugs.

"The respiratory depression data we show is phenomenal for both fentanyl and carfentanil, which brings us hope that this approach will work to treat a number of opioid-related maladies," Janda says.

A long way from 'miracle drug'

Opioids are a diverse class of drugs that have been used to relieve pain for more than 200 years, although the landscape has taken a stark turn in recent decades. The pain drug morphine, isolated from opium, was heralded as a miracle drug in the early 1800s. Not long after, drug makers created a synthetic form, heroin, as a supposedly non-addictive morphine substitute. (The problematic nature of the drug became clear in the 1920s, prompting regulation.)

However, it wasn't until the late 1990s that opioids began to trigger a public health emergency marked by widespread overuse of opioid medications, both from prescriptions and illegal sale of the drugs.

Today, the problem has reached a new crescendo. In December, the Centers for Disease Control and Prevention declared the highest number of overdose deaths ever recorded in a 12-month period, with synthetic opioids--primarily fentanyl, created in illegal labs--as the main source.

Also deemed a terrorist weapon

Fentanyl is much stronger than most other opioids, up to 100 times stronger than morphine. Carfentanil, meanwhile, is up to 10,000 times more potent than morphine, Janda says, making it the deadliest of all. It is often used in veterinary medicine to sedate large animals such as elephants.

Although carfentanil is not as well-known as a street drug, it is an increasingly used as an adulterant in heroin and cocaine, leading to unexpected drug overdoses. It can also lead to overdose deaths from accidental exposure, such as in veterinary or police settings. Having an emergency vaccine on hand can thwart those risks.

Janda says synthetic opioids also are considered a terrorist weapon; they can be made in large quantities and in several forms, including tablets, powder and spray. They are readily absorbed through the skin or through inhalation. A single terrorist attack using carfentanil could be deadly for large numbers of people, he says.

"Unfortunately, the rise in carfentanil and fentanyl overdose incidents is placing further strain on already overwhelmed public health systems currently battling a pandemic," Janda says. "We look forward to continuing our vaccine research and translating it to the clinic, where we can begin to make an impact on the opioid crisis."

Credit: 
Scripps Research Institute

Scientists establish multiple primate models of SARS-CoV-2 airborne infection

Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE. Their work demonstrates that any of these species may be useful for testing vaccines and therapies in response to the COVID-19 pandemic, which has resulted in over 104 million cases and more than 2 million deaths worldwide in the past year.

Given the global impact of COVID-19, experts are working rapidly to develop medical countermeasures, and testing in animal models is critically important to evaluate the efficacy of these products. Recent studies suggest that aerosol transmission may be the most prevalent route of human exposure to SARS-CoV-2, the virus that causes COVID-19. Until now, however, the African green monkey was the only nonhuman primate model studied in efforts to replicate airborne transmission of the virus.

In this paper, first author Sara C. Johnston, Ph.D., and colleagues at the U.S. Army Medical Research Institute of Infectious Diseases analyzed two additional nonhuman primate species as potential models of COVID-19 in humans.

The team exposed cynomolgus macaques, rhesus macaques, and African green monkeys to SARS-CoV-2 using a model system invented at USAMRIID that generates a controlled dosage of highly respirable airborne particles within a sealed chamber. Scientists then monitored the animals for up to 18 days, documenting clinical disease findings and comparing them to human cases. All three species developed disease that resembled mild acute respiratory disease in human patients, and all had corresponding viral loads in nasal and throat swabs. Respiratory abnormalities and viral shedding also were observed for all animals.

"In general, the clinical disease characteristics we noted are similar to those described by others in the field," Johnston commented. "One exception is the presence of fever in all cynomolgus macaques on this study. This finding was exclusive to cynomolgus macaques and was detected only by using implanted body temperature-monitoring devices. Since fever is a hallmark of COVID-19 for human patients, this represents an important clinical finding."

Developing animal models is a complex process, according to Johnston. Variables include the species selected, the dose of virus used, and the route of exposure, with the goal being to combine these elements to create a model that replicates human disease as closely as possible.

Overall, the USAMRIID data indicate that macaques, in addition to African green monkeys, can be infected by airborne SARS-CoV-2, providing natural transmission models for evaluation of vaccines and treatments.

"In addition to determining critical disease parameters associated with disease progression, and establishing correlations between primate and human COVID-19, this work directly contributes to the advancement of medical countermeasures against the virus," said USAMRIID senior author Aysegul Nalca, M.D., Ph.D. She said the team's next step is to demonstrate the utility of these primate models for the continuing evaluation of vaccine and therapeutic candidates. Having more than one viable model in place, she added, will help to facilitate a more rapid deployment of new medical products to mitigate the COVID-19 pandemic.

Credit: 
US Army Medical Research Institute of Infectious Diseases

Study links brain cells to depression

A new study further highlighting a potential physiological cause of clinical depression could guide future treatment options for this serious mental health disorder. Published in Frontiers in Psychiatry, researchers show differences between the cellular composition of the brain in depressed adults who died by suicide and non-psychiatric individuals who died suddenly by other means.

"We found a reduced number of astrocytes, highlighted by staining the protein vimentin, in many regions of the brain in depressed adults," reports Naguib Mechawar, a Professor at the Department of Psychiatry, McGill University, Canada, and senior author of this article. "These star-shaped cells are important because they support the optimal function of brain neurons. Our findings confirm and extend previous research implicating astrocytes in the pathology of depression."

Major depressive disorder, also referred to as clinical depression, causes a persistent feeling of sadness and loss of interest, leading to a variety of serious emotional and physical problems. With approval from the Research Ethics Board, the team at the Douglas Institute (McGill University) used postmortem analysis to add weight to the theory that astrocytes play a role in this disorder.

Same shape different number

"We analyzed the astrocytes in the brain by staining specific proteins found in their structure -- vimentin and GFAP. Vimentin staining has not been used before in this context, but it provides a clear, complete and unprecedented view of the entire microscopic structure of these cells," explains Liam O'Leary, who completed this study at McGill University as part of his PhD research. "Using a microscope, we counted the number of astrocytes in cross sections of the brain, enabling us to estimate how many were in each region. We also analyzed the 3D structure of over three hundred individual astrocytes for any differences."

The postmortem analysis revealed that in depression, while the number of astrocytes differed, they have a similar structure to psychiatrically healthy individuals.

"This research indicates that depression may be linked to the cellular composition of the brain. The promising news is that unlike neurons, the adult human brain continually produces many new astrocytes. Finding ways that strengthen these natural brain functions may improve symptoms in depressed individuals," says Mechawar.

Target for treatment

"Our study provides a strong rationale for developing drugs that counteract the apparent loss of astrocytes in depression," says O'Leary. "No antidepressants have yet been developed to target these cells directly, although the leading theory for the rapid antidepressant action of ketamine, a relatively new treatment option, is that it corrects for astrocyte abnormality."

Future research hopes to address some limitations of the current study and to look deeper at the association of astrocytes with depression.

"While this study is the most comprehensive so far, it was only conducted with samples from male patients. We want to widen this study to investigate samples from female patients since it is now known that the neurobiology of depression differs quite significantly between men and women," says Mechawar, who also acknowledges the critical role of the donors and their families.

"Tissue donation to scientific research allows us to better understand the cellular and molecular dysfunctions underlying brain disorders, thereby supporting the development of better mental healthcare treatments."

If you or someone you know is affected by depression, please find help now. The International Association for Suicide Prevention provide a list of crisis centers across the world that can offer support in your region.

Credit: 
Frontiers

Helping consumers save more by bursting their bubble of financial responsibility

Researchers from University of Notre Dame, York University (Canada), and University of New England (Australia) published a new paper in the Journal of Marketing that identifies a novel reason why people under-save and demonstrates a simple, short, and inexpensive intervention that increases intentions to save and actual savings.

The study, forthcoming in the Journal of Marketing, is titled "Popping the Positive Illusion of Financial Responsibility Can Increase Personal Savings: Applications in Emerging and Western Markets" and is authored by Emily Garbinsky, Nicole Mead, and Daniel Gregg.

People around the world are not saving enough money. Since increasing personal savings is critical for individual and societal welfare, many researchers have tried to identify reasons why people under-save. Most of these reasons, however, do not lend themselves to behavioral interventions.

Garbinsky explains that "We show that one reason people under-save is because they hold the positive illusion of being financially responsible. In other words, most people hold positively distorted beliefs about how well they save and manage their money because this allows them to feel good about themselves. In our study, we show that most people view themselves as more financially responsible than their average peer, which is statistically impossible."

Building on this finding, the research demonstrates that offsetting this positive illusion of financial responsibility motivates people to restore this diminished self-view. In other words, when people perceive that their past financial behaviors have fallen short of their desired standard (in this case, to be a financially responsible person), they enact behaviors to close the gap (in this case, by allocating more money to their savings).

"As part of the study," Gregg says, "we created what we call the 'superfluous-spender intervention' that influenced people to believe they were not saving as well as they believed. Across a series of six experiments, we show that people receiving the superfluous-spender intervention increased both intentions to save and actual savings relative to those who do not receive the intervention. Our theoretical reasoning is that the intervention increases saving by inducing one's desire to restore diminished perceptions of financial responsibility."

The study also sheds light on two managerially relevant factors about when and for whom the intervention is most likely to be effective. More specifically, the intervention is only expected to increase savings if people can draw perceptions about their own level of financial responsibility. Because past research has shown that people reach conclusions about themselves only when past behavior was freely chosen, the intervention is only effective when past financial behaviors are highlighted that were under one's control and therefore attributable to the self. Also, the intervention is most effective among people who are motivated to perceive themselves as financially responsible.

In closing, although it may be tempting to think that the savings silver bullet is to make consumers feel better about themselves in the financial domain, the empirical data from this research suggest otherwise. "We illuminate that the illusion of financial responsibility is a novel antecedent to saving and that financial stakeholders can combat this self-enhancing bias to encourage consumers to commit to saving more," says Mead.

Credit: 
American Marketing Association

Politicians must be held to account for mishandling the pandemic

Politicians around the world must be held to account for mishandling the covid-19 pandemic, argues a senior editor at The BMJ today.

Executive editor, Dr Kamran Abbasi, argues that at the very least, covid-19 might be classified as 'social murder' that requires redress.

Today 'social murder' may describe a lack of political attention to the conditions in which people are born, grow, live, work and age that exacerbate the pandemic.

When politicians and experts say that they are willing to allow tens of thousands of premature deaths, for the sake of population immunity or in the hope of propping up the economy, is that not premeditated and reckless indifference to human life, he asks?

If policy failures lead to recurrent and mistimed lockdowns, who is responsible for the resulting non-covid excess deaths?

And when politicians wilfully neglect scientific advice, international and historical experience, and their own alarming statistics and modelling, because to act goes against their political strategy or ideology, is that lawful?

He acknowledges that any nation's laws on political misconduct or negligence are complex, and not designed to react to unprecedented events, but says after more than 2 million people have died, "we must not look on impotently as elected representatives around the world remain unaccountable and unrepentant."

If citizens feel disempowered, who might hold negligent politicians to account, he asks?

He points out that official scientific advisers have often struggled to convince politicians to act until it is too late or kept silent to avoid public criticism, while much of the media is complicit too, "worried about telling pandemic truths to their readers and viewers, owners, and political friends."

It is this environment that has allowed covid denial to flourish, for unaccountability to prevail, and for the great lies of 'world-beating' pandemic responses to be spun, argues Abbasi.

When citizens find no accountability among their leaders, and feel unsupported by experts and the media, the law remains one form of redress, he writes. Indeed, some legal avenues, including criminal negligence and misconduct in public office, are being explored, although proving any such claims will be difficult and drawn out.

What's left then in this circumstance is for citizens to lobby their political representatives for a public inquiry; for professionals in law, science, medicine, and the media, as well as holders of public office, to put their duty to the public above their loyalty to politicians and to speak out, to dissent lawfully, to be active in their calls for justice, especially for the disadvantaged.

"Politicians must be held to account by legal and electoral means, indeed by any national and international constitutional means necessary. State failures that led us to 2 million deaths are 'actions' and 'inactions' that should shame us all," he concludes.

In a linked editorial, Clare Wenham at the London School of Economics asks what went wrong in the global governance of covid-19?

Looking at the latest report from the Independent Panel for Pandemic Preparedness and Response, she argues that the system we have established for global health security cannot respond adequately to a health emergency.

She calls for collaborative action to fix the identified weaknesses, but acknowledges that given the politicisation of responses globally, any efforts to develop a standardised response to health emergencies will have to overcome serious challenges to secure agreement among all member states.

"We need a targeted review that names and shames governments, rather than obscuring them with generalisations," she writes. "I look forward to bolder reports from the independent panel that consider not only the economic and social effect of the pandemic but the failure of Western governments too."

Credit: 
BMJ Group

Epigenomic map reveals circuitry of 30,000 human disease regions

CAMBRIDGE, MA -- Twenty years ago this month, the first draft of the human genome was publicly released. One of the major surprises that came from that project was the revelation that only 1.5 percent of the human genome consists of protein-coding genes.

Over the past two decades, it has become apparent that those noncoding stretches of DNA, originally thought to be "junk DNA," play critical roles in development and gene regulation. In a new study published today, a team of researchers from MIT has published the most comprehensive map yet of this noncoding DNA.

This map provides in-depth annotation of epigenomic marks -- modifications indicating which genes are turned on or off in different types of cells -- across 833 tissues and cell types, a significant increase over what has been covered before. The researchers also identified groups of regulatory elements that control specific biological programs, and they uncovered candidate mechanisms of action for about 30,000 genetic variants linked to 540 specific traits.

"What we're delivering is really the circuitry of the human genome. Twenty years later, we not only have the genes, we not only have the noncoding annotations, but we have the modules, the upstream regulators, the downstream targets, the disease variants, and the interpretation of these disease variants," says Manolis Kellis, a professor of computer science, a member of MIT's Computer Science and Artificial Intelligence Laboratory and of the Broad Institute of MIT and Harvard, and the senior author of the new study.

MIT graduate student Carles Boix is the lead author of the paper, which appears today in Nature. Other authors of the paper are MIT graduate students Benjamin James and former MIT postdocs Yongjin Park and Wouter Meuleman, who are now principal investigators at the University of British Columbia and the Altius Institute for Biomedical Sciences, respectively. The researchers have made all of their data publicly available for the broader scientific community to use.

Epigenomic control

Layered atop the human genome -- the sequence of nucleotides that makes up the genetic code -- is the epigenome. The epigenome consists of chemical marks that help determine which genes are expressed at different times, and in different cells. These marks include histone modifications, DNA methylation, and how accessible a given stretch of DNA is.

"Epigenomics directly reads the marks used by our cells to remember what to turn on and what to turn off in every cell type, and in every tissue of our body. They act as post-it notes, highlighters, and underlining," Kellis says. "Epigenomics allows us to peek at what each cell marked as important in every cell type, and thus understand how the genome actually functions."

Mapping these epigenomic annotations can reveal genetic control elements, and the cell types in which different elements are active. These control elements can be grouped into clusters or modules that function together to control specific biological functions. Some of these elements are enhancers, which are bound by proteins that activate gene expression, while others are repressors that turn genes off.

The new map, EpiMap (Epigenome Integration across Multiple Annotation Projects), builds on and combines data from several large-scale mapping consortia, including ENCODE, Roadmap Epigenomics, and Genomics of Gene Regulation.

The researchers assembled a total of 833 biosamples, representing diverse tissues and cell types, each of which was mapped with a slightly different subset of epigenomic marks, making it difficult to fully integrate data across the multiple consortia. They then filled in the missing datasets, by combining available data for similar marks and biosamples, and used the resulting compendium of 10,000 marks across 833 biosamples to study gene regulation and human disease.

The researchers annotated more than 2 million enhancer sites, covering only 0.8 percent of each biosample, and collectively 13 percent of the genome. They grouped them into 300 modules based on their activity patterns, and linked them to the biological processes they control, the regulators that control them, and the short sequence motifs that mediate this control. The researchers also predicted 3.3 million links between control elements and the genes that they target based on their coordinated activity patterns, representing the most complete circuitry of the human genome to date.

Disease links

Since the final draft of the human genome was completed in 2003, researchers have performed thousands of genome-wide association studies (GWAS), revealing common genetic variants that predispose their carriers to a particular trait or disease.

These studies have yielded about 120,000 variants, but only 7 percent of these are located within protein-coding genes, leaving 93 percent that lie in regions of noncoding DNA.

How noncoding variants act is extremely difficult to resolve, however, for many reasons. First, genetic variants are inherited in blocks, making it difficult to pinpoint causal variants among dozens of variants in each disease-associated region. Moreover, noncoding variants can act at large distances, sometimes millions of nucleotides away, making it difficult to find their target gene of action. They are also extremely dynamic, making it difficult to know which tissue they act in. Lastly, understanding their upstream regulators remains an unsolved problem.

In this study, the researchers were able to address these questions and provide candidate mechanistic insights for more than 30,000 of these noncoding GWAS variants. The researchers found that variants associated with the same trait tended to be enriched in specific tissues that are biologically relevant to the trait. For example, genetic variants linked to intelligence were found to be in noncoding regions active in the brain, while variants associated with cholesterol level are in regions active in the liver.

The researchers also showed that some traits or diseases are affected by enhancers active in many different tissue types. For example, they found that genetic variants associated with coronary heart disease (CAD) were active in adipose tissue, coronary arteries, and the liver, among many other tissues.

Kellis' lab is now working with diverse collaborators to pursue their leads in specific diseases, guided by these genome-wide predictions. They are profiling heart tissue from patients with coronary artery disease, microglia from Alzheimer's patients, and muscle, adipose, and blood from obesity patients, which are predicted mediators of these disease based on the current paper, and his lab's previous work.

Many other labs are already using the EpiMap data to pursue studies of diverse diseases. "We hope that our predictions will be used broadly in industry and in academia to help elucidate genetic variants and their mechanisms of action, help target therapies to the most promising targets, and help accelerate drug development for many disorders," Kellis says.

Credit: 
Massachusetts Institute of Technology

First images of muon beams

image: The scientists were able to use their technique to take images of muons and positrons as they passed through water and a plastic scintillator.

Image: 
Seiichi Yamamoto

A new technique has taken the first images of muon particle beams. Nagoya University scientists designed the imaging technique with colleagues in Osaka University and KEK, Japan and describe it in the journal Scientific Reports. They plan to use it to assess the quality of these beams, which are being used more and more in advanced imaging applications.

Muons are charged particles that are 207 times the mass of electrons. They naturally form when cosmic rays strike atoms in the upper atmosphere, showering down onto every part of Earth's surface. They can penetrate through hundreds of meters of solids before being absorbed.

Scientists have used naturally occurring muon particles as a way to peek through huge solid structures. For example, in 2017 scientists announced they had found a hidden chamber inside the Khufu Pyramid of Giza by comparing the muon intensities measured by detectors located inside and outside the pyramid. Particle accelerator facilities can now also generate muon beams, which are used in a variety of applications, like non-destructive X-ray fluorescence spectroscopy. Muon beams are also expected to be adapted for cancer radiotherapy.

Nagoya University biomedical nuclear scientist Seiichi Yamamoto and colleagues developed a new imaging technique that they say shows promise for quality assessment and research of muon beams, and should be of benefit for muon radiotherapy in the future.

The technique depends on a phenomenon that occurs when charged particles travel through transparent media, like water. Water slows light down relative to high-energy particles. Particles moving faster than light cause something similar to the sonic boom we hear when a jet plane breaks through the sound barrier. In the case of the particles, an 'optical boom', called the Cherenkov effect, causes a brief flash.

Yamamoto and his colleagues imaged this effect with a special camera when a muon beam was directed through water or a plastic scintillator block. The technique allowed them to image muons and the positrons that form when muons decay. This helped them measure the beam's range through the water or plastic scintillator, and the deviation of its momentum, as well as clarify the direction of positron movement.

"The system is compact, low cost and easy to use, showing promise as a tool for quality assessment in muon beam facilities," says Yamamoto.

Credit: 
Nagoya University

Dynamics of radiocesium in forests after the Fukushima disaster: Concerns and some hope

image: Scientists compile available data and analyses on the flow of radionuclides to gain a more holistic understanding

Image: 
Forestry and Forest Products Research Institute, Japan

After the Chernobyl disaster of 1986, the 2011 Fukushima Daiichi nuclear power plant (FDNPP) disaster was the second worst nuclear incident in history. Its consequences were tremendous for the Japanese people and now, almost a decade later, they can still be felt both there and in the rest of the world. One of the main consequences of the event is the release of large amounts of cesium-137 (137Cs)--a radioactive "isotope" of cesium--into the atmosphere, which spread farther away from the power plant through wind and rainfall.

Considering the massive threat posed by 137Cs to the health of both humans and ecosystems, it is essential to understand how it has distributed and how much of it still lingers. This is why the International Atomic Energy Agency (IAEA) has recently published a technical document on this specific issue. The fifth chapter of this "Technical Document (TECDOC)," titled "Forest ecosystems," contains an extensive review and analysis of existing data on 137Cs levels in Fukushima prefecture's forests following the FDNPP disaster.

The chapter is based on an extensive study led by Assoc. Prof. Shoji Hashimoto from the Forestry and Forestry Products Research Institute, Japan, alongside Dr. Hiroaki Kato from the University of Tsukuba, Japan, Kazuya Nishina from the National Institute of Environmental Studies, Japan, Keiko Tagami from the National Institutes for Quantum and Radiological Science and Technology, Japan, George Shaw from the University of Nottingham, UK, and Yves Thiry from the National Agency for Radioactive Waste Management (ANDRA), France, and several other experts in Japan and Europe.

The main objective of the researchers was to gain a better understanding of the dynamics of 137Cs flow in forests. The process is far from straightforward, as there are multiple elements and variables to consider. First, a portion of 137Cs-containing rainfall is intercepted by trees, some of which is absorbed, and the rest eventually washes down onto the forest floor. There, a fraction of the radiocesium absorbs into forest litter and the remainder flows into the various soil and mineral layers below. Finally, trees, other plants, and mushrooms incorporate 137Cs through their roots and mycelia, respectively, ultimately making it both into edible products harvested from Fukushima and wild animals.

Considering the complexity of 137Cs flux dynamics, a huge number of field surveys and gatherings of varied data had to be conducted, as well as subsequent theoretical and statistical analyses. Fortunately, the response from the government and academia was considerably faster and more thorough after the FDNPP disaster than in the Chernobyl disaster, as Hashimoto explains: "After the Chernobyl accidents, studies were very limited due to the scarce information provided by the Soviet Union. In contrast, the timely studies in Fukushima have allowed us to capture the early phases of 137Cs flow dynamics; this allowed us to provide the first wholistic understanding of this process in forests in Fukushima."

Understanding how long radionuclides like 137Cs can remain in ecosystems and how far they can spread is essential to implement policies to protect people from radiation in Fukushima-sourced food and wood. In addition, the article also explores the effectiveness of using potassium-containing fertilizers to prevent the uptake of 137Cs in plants. "The compilation of data, parameters, and analyses we present in our chapter will be helpful for forest remediation both in Japan and the rest of the world," remarks Hashimoto.

When preventive measures fail, the only remaining option is trying to fix the damage done--in the case of radiation control, this is only possible with a comprehensive understanding of the interplay of factors involved.

In this manner, this new chapter will hopefully lead to both timely research and more effective solutions should a nuclear disaster happen again.

Credit: 
Forestry and Forest Products Research Institute

In vitro study helps explain how Zika virus passes from mother to fetus during pregnancy

image: Ozlem Guzeloglu-Kayisli, PhD, associate professor of obstetrics and gynecology at the USF Health Morsani College of Medicine, was the paper's lead author and a co-principal investigator of the Zika study.

Image: 
Photo courtesy of USF Health

Tampa, FL (Feb. 3, 2021) -- A preclinical study by a University of South Florida Health (USF Health) Morsani College of Medicine research team has discovered a new mechanism for how Zika virus can pass from mothers to their children during pregnancy - a process known as vertical transmission.

The researchers showed, for the first time, that specialized cells lining the uterus (maternal decidual cells) act as reservoirs for trimester-dependent transmission of the virus through the placenta - accounting for both the fetus's greater susceptibility to first-trimester Zika infection and for the more serious congenital defects observed in early versus late pregnancy. They also report that the agent tizoxanide inhibits ZIKA virus in maternal decidual cells grown in the lab, offering promise for preventing perinatal transmission that can cause devastating malformations and brain damage in developing fetuses and infants.

The findings appeared Dec. 1, 2020 in the Journal of Immunology.

The study was led by co-principal investigators Ozlem Guzeloglu-Kayisli, PhD, a USF Health associate professor of obstetrics and gynecology, and Charles J. Lockwood, MD, USF Health senior vice president, dean of the Morsani College of Medicine, and a professor of obstetrics and gynecology specializing in maternal-fetal medicine.

"If we can better understand Zika virus vertical transmission and successfully block infection in maternal (decidual) cells early in the pregnancy, the virus will not pass through the placenta to reach the fetus and it is less likely to cause severe abnormalities," said Guzeloglu-Kayisli, the paper's lead author.

The widespread global alarm caused by the spread of mosquito-borne Zika virus throughout the Americas in 2015-2016 dissipated after the virus all but disappeared in 2017. Yet, resurgence remains possible in areas where the Aedes aegypti mosquito is prevalent, and there is no treatment or vaccine available for Zika virus infection.

While most Zika-infected adults show no symptoms, the virus can cause minor flu-like symptoms, and in rare cases has been associated with Guillain-Barre syndrome. However, Zika poses the most concern for pregnant women, because up to one in 10 newborns of affected mothers suffer Zika-associated birth defects, including smaller than normal head size (microcephaly) that can lead to developmental disabilities and other health problems. Zika has also been linked to pregnancy complications, including preterm birth, preeclampsia and miscarriage. Moreover, timing appears important. Mothers infected in the first trimester are much more likely to have babies with severe Zika birth defects than mothers infected in the third semester.

The placenta, the organ supplying maternal oxygen and nutrients to the growing fetus, has ways to prevent most pathogens, including viruses, from crossing its protective maternal-fetal barrier. A subtype of fetally-derived placental cells known as syncytiotrophoblasts, in direct contact with maternal blood, are assumed to be the site where the Zika virus enters the placenta, leading to potential fetal infection. However, Dr. Ozlem Guzeloglu-Kayisli said, these particular trophoblasts resist Zika virus attachment and replication.

To learn more about how Zika gets through the placental wall, the USF Health team began by investigating the cellular and molecular mediators of Zika virus replication. Among their key findings, the researchers:

- Showed that specialized uterine cells from both pregnant and nonpregnant women were highly infectable by Zika virus. These immunologically active decidual cells, which line the uterus in preparation for and during pregnancy, form the maternal part of the placenta closest to the fetus.

- Identified a more than 10,000-fold higher expression of the Zika virus attachment-entry receptor in the maternal decidual cells than in the fetal trophoblasts. Once inside the maternal cells, the Zika virus (an RNA virus) hijacks the cellular machinery to make proteins needed to copy its genetic material and churn out new viral particles. The proliferation of viral particles released from the maternal cells are then transmitted through branch-like vascular projections (villi) on the placenta's surface layer where they can infect fetal trophoblast cells otherwise resistant to Zika virus.

- Found that the efficiency of viral replication was significantly greater in first-trimester decidual cells than in those from term pregnancies.

- Concluded that maternal (decidual) cells likely serve as the source for initial Zika virus infection and enhance subsequent transmission through the placenta to the fetus. "Moreover, trimester-dependent responses of decidual cells to Zika virus help to explain why pregnant women are susceptible to Zika infection and why the subsequent effects are more detrimental in the first trimester than in late pregnancy," the study authors wrote.

- Demonstrated that tizoxanide, the active metabolite of FDA-approved antiparasitic drug nitazoxanide, effectively impeded Zika virus infection in both maternal decidual cells and fetal trophoblast cells. The drug has been shown preclinically to inhibit a broad range of flu-like viruses and is being tested clinically against coronavirus. The finding warrants further testing of tizoxanide to block perinatal transmission of Zika virus and thereby protect the fetus from harmful outcomes, the researchers conclude.

Credit: 
University of South Florida (USF Health)

Retrained generic antibodies can recognize SARS-CoV-2

image: Double-faced peptide-based boosters are computationally designed to allow recognition of SARS-CoV-2 (grey, schematic) by Hepatitis B antibodies. One booster face made of ACE2-mimic peptides (red) can bind to the receptor binding domain of SARS-CoV-2 (blue). The other booster face composed of a Hepatitis B core-antigen (orange) can target the Hepatitis B antibody fragment (green). This approach can provide a cheap and efficient neutralization of emerging pathogens by generic antibodies.

Image: 
UIC

The SARS-CoV-2, the new coronavirus behind the current pandemic, infects humans by binding its surface-exposed spike proteins to ACE2 receptors exposed on the cell membranes.

Upon a vaccination or a real infection, it takes several weeks before the immunity develops antibodies that can selectively bind to these spike proteins. Such antibody-labeled viruses are neutralized by the natural killer and T cells operated by the human immunity.

An alternative approach to train the immunity response is offered by researchers at the University of Illinois Chicago and California State University at Sacramento who have developed a novel strategy that redirects antibodies for other diseases existing in humans to the spike proteins of SARS-CoV-2.

In their study published by the Journal of Physical Chemistry Letters, the team proposes using peptide-based double-faced "booster" inhibitors, with one face binding to the spike proteins of SARS-CoV-2 and the other face binding to generic hepatitis B antibodies.

"Once the SARS-CoV-2 viruses become labeled by the hepatitis B antibodies via intermediate boosters, the viruses will be neutralized. This universal approach allows a dramatic shortening of the response time upon real infections, which can be critical in certain patients or conditions," said Petr Král, UIC professor of chemistry, physics, pharmaceutical sciences and chemical engineering, and senior author on the paper.

Král and Yanxiao Han, who recently earned a Ph.D. in chemistry at UIC and is first author on the paper, believe the study could provide guidance in the preparation of generic therapeutics against emerging pathogens with the combined advantages of small-protein and antibody therapies.

"The dramatic impact which novel viruses can have on humans could be fast mitigated in the absence of their vaccination if generic antibodies present within them are temporarily retrained to recognize these viruses," the researchers wrote.

In a study published last spring, Král and Han extracted different peptides from ACE2 that interact directly with the viral spike protein.

"We investigated potential COVID-19 therapeutics using computer simulations based on the X-ray crystal structure of the receptor-binding domain of SARS-CoV-2 when it is bound to ACE2," Král said. "Similar to our latest study, identifying these kinds of inhibitors could lead to new treatments to combat the coronavirus."

Credit: 
University of Illinois Chicago

Flower diversity may mitigate insecticide effects on wild bees

image: View from above showing the experimental setup

Image: 
F Klaus/University of Göttingen

A higher diversity of flowering plants increases the breeding success of wild bees and may help compensate for the negative effects of insecticides. This is what researchers from the Universities of Göttingen and Hohenheim, as well as the Julius Kühn Institute, have found in a large-scale experimental study. The results have been published in the scientific journal Ecology Letters.

In their experiment, the researchers investigated how successfully the wild bee Osmia bicornis (red mason bee) reproduced. Red mason bees are important for both ecological and economic reasons. The wild bees were experimentally kept in more than 50 large enclosure cages with flower mixtures of varying wild plant diversity and insecticide-treated oilseed rape. Subsequently, the reproductive success of the wild bees, as measured by the number of their brood cells and emerged offspring, was investigated over several months.

The research team found that the number of cells that the wild bees created for their offspring where species-rich flowering mixtures were available was twice that of wild bees where only oilseed rape was available. The reproductive success of the wild bees, which have to supply their offspring with pollen and nectar, increased both in cages with a large diversity of flowering plants and where there were particularly important plant species. In contrast, if oilseed rape treated with clothianidin (from the neonicotinoid class of insecticides), was available to the bees, this had a negative effect on their reproductive success. However, this negative effect of the insecticide only occurred in cages with oilseed rape monocultures, which suggests that such effects can be mitigated by alternative food resources from species-rich flowering mixtures.

The study shows that both the diversity of flowering plants and exposure to insecticides significantly influence the reproductive success of wild bees, and shows that a high diversity of flowering plants could compensate for the negative effects of insecticides. "One possible explanation is that bee larvae benefit from additional nutrients, and are exposed to fewer insecticides, when the pollen of other plant species besides oilseed rape is available to them," explains Felix Klaus, first author of the study and PhD student in the Agroecology Group at Göttingen University. "Our results emphasise the important role of species-rich resources of flowers for wild bees," adds Professor Ingo Grass, head of the Department of Ecology of Tropical Agricultural Systems at the University of Hohenheim. "If sufficiently diverse flowers are available in the agricultural landscape, this could counteract the negative effects of monocultures and insecticides," says Professor Teja Tscharntke, Head of the Agroecology Group at Göttingen University.

Credit: 
University of Göttingen

A deadly fungus is killing frogs, but the bacteria on their skin could protect them

Researchers in Costa Rica have found that some bacteria on the skin of amphibians prevent growth of the fungus responsible for what has been dubbed 'the amphibian apocalypse'.

Published in the journal Microbiology, the research identified a number of bacteria which could growth of the fungus Batrachochytrium dendrobatidis (Bd). One particularly dangerous strain of the fungus, called BdGPL-2, is responsible for mass amphibian die-offs around the world.

The fungus infects the skin of amphibians, breaking down the cells. As amphibians breathe and regulate water through their skin, infection is often deadly. It is believed that almost 700 species of amphibian are vulnerable to the fungus, and Bd has led to the extinction of 90 amphibian species.

In order to investigate why some amphibian populations in Costa Rica were more resilient to Bd that others, a research group led by Dr Adrian Pinto, Professor at the University of Costa Rica sampled the circulating strains of Bd and the skin microbiome of amphibians at different sites.

To do this, the research group collected wild amphibians from areas of Costa Rica which had a history of Bd outbreaks. "Bd has previously been widely detected in Costa Rica, but this is the first study to isolate and compare the characteristics of different isolates," said Dr Pinto, "our work showed that the circulating strains of the pathogenic fungus belong to a highly virulent global strain known as BdGPL-2."

They found that the bacteria on the skin of some surviving amphibians prevented growth of the fungus in the lab. "Amphibian species that survived decline harbor bacteria on their skin capable of inhibiting the growth of the pathogen. However, this inhibitory capacity varies according to which strain of the fungus is being tested," said Dr Pinto. "These findings suggest that locally adapted skin bacteria may offer protection from the disease."

Although the researchers expected to see the highly virulent strain BdGPL-2 in Costa Rica, they did not expect to see so much variation in circulating strains. "We were surprised of the phenotypic variations among the pathogen isolates, including their different responses to the antagonistic bacteria," said Dr Pinto. "Local pathogen adaptations must be considered when designing mitigation strategies for this disease."

Dr Pinto hopes to combine their findings with other disease control strategies to protect amphibian populations from decimation by Bd: "We will further study the ability of skin bacteria to protect amphibians against disease, as another tool to combat this plague alongside the creation of climate shelters and fostering the amphibians' own immune system," he said.

Costa Rica is one of the countries that suffered a dramatic loss of amphibian species between the 1980 and 1990. In Costa Rica, there are currently 64 species of amphibians in some risk category according to the International Union for the Conservation of Nature. Species classified as critically endangered include the Holdridge's Toad (Incilius holdridgei), a native species found only in the mountain ranges of the central region; The Variable Harlequin Frog (Atelopus varius), a river species very sensitive to Bd, and several species of river tree frogs of the genus Isthmohyla that live in cold currents in high areas, a habitat where Bd proliferates successfully.

Amphibians are one of the most diverse groups in the tropics and represent crucial links in food webs. Protecting them keeps ecosystems healthy since biological diversity is the basis for resilient forests, thus helping control pests and zoonotic infections.

Credit: 
Microbiology Society